Generative AI in Healthcare Market Sharpens Competition as Abridge Raises US$300 Million for Clinical Workflow Expansion
Abridge announced a US$300 million Series E funding round in June 2025, led by Andreessen Horowitz with participation from Khosla Ventures. At the announcement, the company reported partnerships with more than 150 U.S. enterprise health systems. The investment supports expansion
Brief summary
What this story is about
Abridge announced a US$300 million Series E funding round in June 2025, led by Andreessen Horowitz with participation from Khosla Ventures. At the announcement, the company reported partnerships with more than 150 U.S. enterprise health systems. The investment supports expansion
Why it matters
Reader takeaways
- Application teams should watch for workflow, data model, integration, and rollout-readiness implications.
- Finance, HR, supply chain, CX, and healthcare leaders may need different follow-up actions from the same story.
- Use the original source link for screenshots, release notes, and configuration details.
SEO context
Topic and keyword map
This brief is filed under Fusion Apps, NetSuite, Oracle Health and enterprise applications.
health & medicineNetSuite newsOracle Fusion Cloud ERPOracle HCM CloudOracle SCM CloudOracle Health news